206 related articles for article (PubMed ID: 25482428)
1. Universal fungal prophylaxis and risk of coccidioidomycosis in liver transplant recipients living in an endemic area.
Kahn A; Carey EJ; Blair JE
Liver Transpl; 2015 Mar; 21(3):353-61. PubMed ID: 25482428
[TBL] [Abstract][Full Text] [Related]
2. Single-center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area.
Lohrmann GM; Vucicevic D; Lawrence R; Steidley DE; Scott RL; Kusne S; Blair JE
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28695649
[TBL] [Abstract][Full Text] [Related]
3. Coccidioidomycosis in liver transplant recipients in an endemic area.
Vucicevic D; Carey EJ; Blair JE
Am J Transplant; 2011 Jan; 11(1):111-9. PubMed ID: 21087416
[TBL] [Abstract][Full Text] [Related]
4. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area.
Blair JE; Douglas DD; Mulligan DC
Transpl Infect Dis; 2003 Mar; 5(1):3-8. PubMed ID: 12791068
[TBL] [Abstract][Full Text] [Related]
5. Coccidioidomycosis in liver transplant recipients relocating to an endemic area.
Blair JE; Douglas DD
Dig Dis Sci; 2004; 49(11-12):1981-5. PubMed ID: 15628738
[TBL] [Abstract][Full Text] [Related]
6. Universal Lifelong Fungal Prophylaxis and Risk of Coccidioidomycosis in Lung Transplant Recipients Living in an Endemic Area.
Truong CN; Nailor MD; Walia R; Cherrier L; Nasar A; Goodlet KJ
Clin Infect Dis; 2022 Jun; 74(11):1966-1971. PubMed ID: 34463704
[TBL] [Abstract][Full Text] [Related]
7. De novo coccidioidomycosis among solid organ transplant recipients 1 or more years after transplant.
Asbury K; Blair JE; August J; Beatty NL; Mi L; Carey EJ; Huskey JL; LeMond LM; Zangeneh TT
Am J Transplant; 2019 Sep; 19(9):2517-2524. PubMed ID: 30811848
[TBL] [Abstract][Full Text] [Related]
8. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
9. Successful kidney transplantation after coccidioidal meningitis.
Kokseng SL; Blair JE
Transpl Infect Dis; 2011 Jun; 13(3):285-9. PubMed ID: 21040281
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients.
Keckich DW; Blair JE; Vikram HR; Seville MT; Kusne S
Transplantation; 2011 Jul; 92(1):88-93. PubMed ID: 21516063
[TBL] [Abstract][Full Text] [Related]
11. Screening Coccidioides serology in kidney transplant recipients: A 10-year cross-sectional analysis.
Phonphok K; Beaird O; Duong T; Datta N; Schaenman J; Bunnapradist S
Transpl Infect Dis; 2018 Oct; 20(5):e12932. PubMed ID: 29809303
[TBL] [Abstract][Full Text] [Related]
12. Coccidioidomycosis in transplant recipients: a primer for clinicians in nonendemic areas.
Vikram HR; Blair JE
Curr Opin Organ Transplant; 2009 Dec; 14(6):606-12. PubMed ID: 19812497
[TBL] [Abstract][Full Text] [Related]
13. The prevention of recrudescent coccidioidomycosis after solid organ transplantation.
Blair JE; Kusne S; Carey EJ; Heilman RL
Transplantation; 2007 May; 83(9):1182-7. PubMed ID: 17496533
[TBL] [Abstract][Full Text] [Related]
14. Targeted versus universal antifungal prophylaxis among liver transplant recipients.
Eschenauer GA; Kwak EJ; Humar A; Potoski BA; Clarke LG; Shields RK; Abdel-Massih R; Silveira FP; Vergidis P; Clancy CJ; Nguyen MH
Am J Transplant; 2015 Jan; 15(1):180-9. PubMed ID: 25359455
[TBL] [Abstract][Full Text] [Related]
15. Coccidioidomycosis in patients who have undergone transplantation.
Blair JE
Ann N Y Acad Sci; 2007 Sep; 1111():365-76. PubMed ID: 17363431
[TBL] [Abstract][Full Text] [Related]
16. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation.
Blair JE; Mulligan DC
Transpl Infect Dis; 2007 Mar; 9(1):78-82. PubMed ID: 17313480
[TBL] [Abstract][Full Text] [Related]
17. Effect of coccidioidomycosis prophylaxis in selecting non-Candida albicans species amongst solid organ transplant recipients in Arizona.
Al-Obaidi MM; Marquez J; Afghan A; Zangeneh TT
Mycoses; 2023 Mar; 66(3):237-241. PubMed ID: 36401812
[TBL] [Abstract][Full Text] [Related]
18. Coccidioidomycosis in hematopoietic stem cell transplant recipients.
Glenn TJ; Blair JE; Adams RH
Med Mycol; 2005 Dec; 43(8):705-10. PubMed ID: 16422300
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
20. A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantation.
Jorgenson MR; Descourouez JL; Marka NA; Leverson GE; Smith JA; Andes DR; Fernandez LA; Foley DP
Transpl Infect Dis; 2019 Oct; 21(5):e13156. PubMed ID: 31390109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
